TuHURA Biosciences, Inc. Gains 60.47%
Tue, Feb 10, 2026 at 07:18 PM
TuHURA Biosciences, Inc. (HURA:NASDAQ) soared at $1.3, a gain of 60.5%. On Tue, Feb 10, 2026, HURA:NASDAQ touched a New 2-Week High of $1.3. The stock appeared on our News Catalysts scanner on Mon, Feb 02, 2026 at 10:54 AM in the 'BIOTECH' category. From Wed, Jan 28, 2026, the stock recorded 33.33% Up Days and 40.00% Green Days
About TuHURA Biosciences, Inc. (HURA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 305.92%
- Jiuzi Holdings, Inc. (JZXN:NASDAQ), 89.71%
- Evommune Inc. (EVMN:NYSE), 70.87%
- TuHURA Biosciences, Inc. (HURA:NASDAQ), 60.47%
- Founder Group Limited (FGL:NASDAQ), 55.96%
- Nektar Therapeutics (NKTR:NASDAQ), 51.07%
- ZW Data Action Technologies Inc. (CNET:NASDAQ), 49.99%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 45.55%
- BiomX Inc. (PHGE:NYSEMKT), 44.37%
- European Wax Center, Inc. (EWCZ:NASDAQ), 43%